SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-067535
Filing Date
2024-08-12
Accepted
2024-08-12 12:03:54
Documents
17
Period of Report
2024-08-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0211125-8k_60degrees.htm   iXBRL 8-K 33834
2 CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION, AS CORRECTED, FILED ON ea021112501ex3-1_60degrees.htm EX-3.1 7629
3 PRESS RELEASE OF 60 DEGREES PHARMACEUTICALS, INC. DATED AS OF AUGUST 6, 2024 ea021112501ex99-1_60degrees.htm EX-99.1 13137
4 GRAPHIC ex99-1_001.jpg GRAPHIC 4075
  Complete submission text file 0001213900-24-067535.txt   291093

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE sxtp-20240812.xsd EX-101.SCH 3792
6 XBRL DEFINITION FILE sxtp-20240812_def.xml EX-101.DEF 26654
7 XBRL LABEL FILE sxtp-20240812_lab.xml EX-101.LAB 36762
8 XBRL PRESENTATION FILE sxtp-20240812_pre.xml EX-101.PRE 25278
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0211125-8k_60degrees_htm.xml XML 6014
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

IRS No.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41719 | Film No.: 241195749
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)